A Small Molecule-Screening Pipeline to Evaluate the Therapeutic Potential of 2-Aminoimidazole Molecules Against Clostridium difficile
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Small Molecule-Screening Pipeline to Evaluate the Therapeutic Potential of 2-Aminoimidazole Molecules Against Clostridium difficile
Authors
Keywords
-
Journal
Frontiers in Microbiology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-06-06
DOI
10.3389/fmicb.2018.01206
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
- (2018) L Clifford McDonald et al. CLINICAL INFECTIOUS DISEASES
- Ridinilazole—a novel antibiotic for treatment of Clostridium difficile infection
- (2018) Niels Steinebrunner et al. Journal of Thoracic Disease
- Zoonotic Transfer of Clostridium difficile Harboring Antimicrobial Resistance between Farm Animals and Humans
- (2017) C. W. Knetsch et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection
- (2017) Mark H. Wilcox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of a 2-aminoimidazole variant as adjuvant treatment for dermal bacterial infections
- (2017) G. Logan Draughn et al. Drug Design Development and Therapy
- Intestinal calcium and bile salts facilitate germination of Clostridium difficile spores
- (2017) Travis J. Kochan et al. PLoS Pathogens
- Primary Outcomes From a Phase 3, Randomized, Double-Blind, Active-Controlled Trial of Surotomycin in Subjects With Clostridium difficile Infection
- (2017) Vicente Boix et al. Open Forum Infectious Diseases
- Control of Clostridium difficile Physiopathology in Response to Cysteine Availability
- (2016) Thomas Dubois et al. INFECTION AND IMMUNITY
- Impact on toxin production and cell morphology inClostridium difficileby ridinilazole (SMT19969), a novel treatment forC. difficileinfection
- (2016) Eugénie Bassères et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- CodY-Dependent Regulation of Sporulation in Clostridium difficile
- (2016) Kathryn L. Nawrocki et al. JOURNAL OF BACTERIOLOGY
- Breakthroughs in the treatment and prevention of Clostridium difficile infection
- (2016) Larry K. Kociolek et al. Nature Reviews Gastroenterology & Hepatology
- Accessory Gene Regulator-1 Locus Is Essential for Virulence and Pathogenesis of Clostridium difficile
- (2016) Charles Darkoh et al. mBio
- The Regulatory Networks That Control Clostridium difficile Toxin Synthesis
- (2016) Isabelle Martin-Verstraete et al. Toxins
- Clostridium difficile infection
- (2016) Wiep Klaas Smits et al. Nature Reviews Disease Primers
- Antibiotic-Induced Alterations of the Gut Microbiota Alter Secondary Bile Acid Production and Allow for Clostridium difficile Spore Germination and Outgrowth in the Large Intestine
- (2016) Casey M. Theriot et al. mSphere
- Mode of Action and Bactericidal Properties of Surotomycin against Growing and Nongrowing Clostridium difficile
- (2015) Mohammed Zahidul Alam et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Small Molecule Inhibitors of Clostridium difficile Toxin B-Induced Cellular Damage
- (2015) John Tam et al. CHEMISTRY & BIOLOGY
- Burden of Clostridium difficile Infection in the United States
- (2015) Fernanda C. Lessa et al. NEW ENGLAND JOURNAL OF MEDICINE
- A small-molecule antivirulence agent for treating Clostridium difficile infection
- (2015) Kristina Oresic Bender et al. Science Translational Medicine
- Toxin Synthesis by Clostridium difficile Is Regulated through Quorum Signaling
- (2015) Charles Darkoh et al. mBio
- Mechanisms of Protection against Clostridium difficile Infection by the Monoclonal Antitoxin Antibodies Actoxumab and Bezlotoxumab
- (2014) Zhiyong Yang et al. INFECTION AND IMMUNITY
- Small-Molecule Suppression of β-Lactam Resistance in Multidrug-Resistant Gram-Negative Pathogens
- (2014) Christopher M. Brackett et al. JOURNAL OF MEDICINAL CHEMISTRY
- Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile
- (2014) Charlie G. Buffie et al. NATURE
- Identifying Keystone Species in the Human Gut Microbiome from Metagenomic Timeseries Using Sparse Linear Regression
- (2014) Charles K. Fisher et al. PLoS One
- Clostridium difficile spore biology: sporulation, germination, and spore structural proteins
- (2014) Daniel Paredes-Sabja et al. TRENDS IN MICROBIOLOGY
- Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection
- (2014) Casey M. Theriot et al. Nature Communications
- Community-acquired Clostridium difficile infection: an increasing public health threat
- (2014) Sahil Khanna et al. Infection and Drug Resistance
- Investigations of the Mode of Action and Resistance Development of Cadazolid, a New Antibiotic for Treatment of Clostridium difficile Infections
- (2013) Hans H. Locher et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroandIn VivoAntibacterial Evaluation of Cadazolid, a New Antibiotic for Treatment of Clostridium difficile Infections
- (2013) Hans H. Locher et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Importance of Toxin A, Toxin B, and CDT in Virulence of an Epidemic Clostridium difficile Strain
- (2013) Sarah A. Kuehne et al. JOURNAL OF INFECTIOUS DISEASES
- Muricholic Acids Inhibit Clostridium difficile Spore Germination and Growth
- (2013) Michael B. Francis et al. PLoS One
- Activity of a Novel Cyclic Lipopeptide, CB-183,315, against Resistant Clostridium difficile and Other Gram-Positive Aerobic and Anaerobic Intestinal Pathogens
- (2012) D. R. Snydman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroandIn VivoCharacterization of CB-183,315, a Novel Lipopeptide Antibiotic for Treatment of Clostridium difficile
- (2012) Carmela T. M. Mascio et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Identification of BfmR, a Response Regulator Involved in Biofilm Development, as a Target for a 2-Aminoimidazole-Based Antibiofilm Agent
- (2012) Richele J. Thompson et al. BIOCHEMISTRY
- Fidaxomicin Inhibits Spore Production in Clostridium difficile
- (2012) Farah Babakhani et al. CLINICAL INFECTIOUS DISEASES
- TheClostridium difficile spo0AGene Is a Persistence and Transmission Factor
- (2012) Laura J. Deakin et al. INFECTION AND IMMUNITY
- Multiple Factors Modulate Biofilm Formation by the Anaerobic Pathogen Clostridium difficile
- (2012) T. Thapa et al. JOURNAL OF BACTERIOLOGY
- Functional interactions between the gut microbiota and host metabolism
- (2012) Valentina Tremaroli et al. NATURE
- Emergence and global spread of epidemic healthcare-associated Clostridium difficile
- (2012) Miao He et al. NATURE GENETICS
- Regulated Virulence Controls the Ability of a Pathogen to Compete with the Gut Microbiota
- (2012) N. Kamada et al. SCIENCE
- Toward a structural understanding of Clostridium difficile toxins A and B
- (2012) Rory N. Pruitt et al. Frontiers in Cellular and Infection Microbiology
- Effect of Antibiotic Treatment on the Intestinal Metabolome
- (2011) L. Caetano M. Antunes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivities of CB-183,315, Vancomycin, and Metronidazole against 556 Strains of Clostridium difficile, 445 Other Intestinal Anaerobes, and 56 Enterobacteriaceae Species
- (2011) Diane M. Citron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genome Sequence of Bifidobacterium breve DPC 6330, a Strain Isolated from the Human Intestine
- (2011) C. M. Guinane et al. JOURNAL OF BACTERIOLOGY
- The Search for Effective Treatment ofClostridium difficileInfection
- (2011) Herbert L. DuPont NEW ENGLAND JOURNAL OF MEDICINE
- Host and Pathogen Factors forClostridium difficileInfection and Colonization
- (2011) Vivian G. Loo et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Intestinal Microbiota Plays a Role in Salmonella-Induced Colitis Independent of Pathogen Colonization
- (2011) Rosana B. R. Ferreira et al. PLoS One
- Synergistic Effects between Conventional Antibiotics and 2-Aminoimidazole-Derived Antibiofilm Agents
- (2010) S. A. Rogers et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
- (2010) Stuart H. Cohen et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Clostridium difficile infection: epidemiology, risk factors and management
- (2010) Ashwin N. Ananthakrishnan Nature Reviews Gastroenterology & Hepatology
- Evolutionary dynamics of Clostridium difficile over short and long time scales
- (2010) M. He et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Isolation and characterization of a bile acid inducible 7α-dehydroxylating operon in Clostridium hylemonae TN271
- (2009) Jason M. Ridlon et al. ANAEROBE
- Gastrointestinal microbiology enters the metagenomics era
- (2009) Daniel N Frank et al. CURRENT OPINION IN GASTROENTEROLOGY
- Characterization of the Sporulation Initiation Pathway of Clostridium difficile and Its Role in Toxin Production
- (2009) S. Underwood et al. JOURNAL OF BACTERIOLOGY
- Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium
- (2009) Richard A Stabler et al. GENOME BIOLOGY
- Mucosal Glycan Foraging Enhances Fitness and Transmission of a Saccharolytic Human Gut Bacterial Symbiont
- (2008) Eric C. Martens et al. Cell Host & Microbe
- Human Microbiota-Secreted Factors Inhibit Shiga Toxin Synthesis by Enterohemorrhagic Escherichia coli O157:H7
- (2008) T. de Sablet et al. INFECTION AND IMMUNITY
- Proposal to reclassify the three biotypes of Bifidobacterium longum as three subspecies: Bifidobacterium longum subsp. longum subsp. nov., Bifidobacterium longum subsp. infantis comb. nov. and Bifidobacterium longum subsp. suis comb. nov.
- (2008) P. Mattarelli et al. INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY
- Emergence of reduced susceptibility to metronidazole in Clostridium difficile
- (2008) S. D. Baines et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of vancomycin against epidemic Clostridium difficile strains in a human gut model
- (2008) S. D. Baines et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Bile Salts and Glycine as Cogerminants for Clostridium difficile Spores
- (2008) J. A. Sorg et al. JOURNAL OF BACTERIOLOGY
- Characterization of Clostridium difficile Strains Isolated from Patients in Ontario, Canada, from 2004 to 2006
- (2008) H. Martin et al. JOURNAL OF CLINICAL MICROBIOLOGY
- The biology and future prospects of antivirulence therapies
- (2007) Lynette Cegelski et al. NATURE REVIEWS MICROBIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started